Erratum to:
Neth Heart J 2017
In the PDF version of the article, Tab. 1 was incorrectly displayed. The corrected version is shown below.
Table 1
Recommendation with level of evidence of timing and duration of antiplatelet therapy peri-CABG
CABG Indication | ||||
|---|---|---|---|---|
Timing | Agent | Stable CAD without stent(s) | Stable CAD with recent stent(s) | ACS with or without stent(s) |
Preoperative | Aspirin | Continue (IA)a
| Continue (IA) | Continue (IA) |
P2Y12 | n.a. | Stop 5–7days (IIA) | Stop 5–7 days (IIA)b
| |
Postoperative | Aspirin | Lifelong (IA) | Lifelong (IA) | Lifyelong (IA) |
P2Y12 | n.a. | Day 1 restart (IIA)c
| Day 1 restart (IIB)d
| |
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
